PACHARAPORN TUNSARAWUT: Open Payments
NPI 1538912613 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 32 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $252 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $252 |
| AstraZeneca Pharmaceuticals LP | 4 | $162 |
| ABBVIE INC. | 5 | $130 |
| PFIZER INC. | 5 | $107 |
| Amgen Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $23 |
| Abbott Laboratories | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
Products named: FARXIGA, Ozempic, ELIQUIS, Rybelsus, UBRELVY, NURTEC ODT, QULIPTA, Wegovy.
Industry payments across VA — which companies pay providers there.
